HEALTHCARE INSIGHTS
HEALTHCARE INSIGHTS
  • Home
  • #Global Trends
  • #Vietnam
  • #M&A
  • #Regulations
  • #Knowledge
    • #Corporate Wellness
    • #Human Resources
    • #Capability Development
    HEALTHCARE INSIGHTS
    HEALTHCARE INSIGHTS

    Tag: #Global Trends

    J&J solidifies oncology leadership in multiple myeloma as Talvey and Darzalex Faspro combo triumphs in early-stage trial

    15/06/2026 Published by Pharma Biz

    J&J solidifies oncology leadership in multiple myeloma as Talvey and Darzalex Faspro combo triumphs in early-stage trial At a plenary... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Draft Amended Food Safety Law: Proposals mandate identity verification for social media vendors and criminalize banned substance usage

    15/06/2026 Published by Pharma Biz

    The Ministry of Justice has officially published the evaluation dossier for the revised draft of the Food Safety Law. Within... Read more

    Category: Uncategorized
    Tags: #Global Trends

    France recalls Novalac formula batch: Manufacturer isolates root cause of color and odor anomalies

    15/06/2026 Published by Pharma Biz

    The French government has officially confirmed the voluntary preventive recall of an infant formula batch executed by Novalac following a... Read more

    Category: Uncategorized
    Tags: #Global Trends

    FDA clears expanded approval for Sanofi’s type 1 diabetes drug Tzield in Stage 3 pediatric cohorts

    13/06/2026 Published by Pharma Biz

    The U.S. Food and Drug Administration (FDA) has formally approved the expanded clinical utilization of Sanofi’s injectable metabolic therapy, Tzield.... Read more

    Category: Uncategorized
    Tags: #Global Trends
    13/06/2026 Published by Pharma Biz

    Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, has formally applauded the decision issued by... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Amgen taps Duke Clinical Research Institute to independently review Tavneos data amid FDA withdrawal proposal

    12/06/2026 Published by Pharma Biz

    U.S. biotechnology giant Amgen has officially retained an independent third-party research institution to conduct an un-biased evaluation of the clinical... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Takeda’s $4 billion TYK2 inhibitor zasocitinib outperforms Bristol Myers’ Sotyktu in head-to-head psoriasis trial

    12/06/2026 Published by Pharma Biz

    Japanese drugmaker Takeda has officially announced positive top-line readouts from a head-to-head clinical trial, demonstrating that its investigational autoimmune candidate,... Read more

    Category: Uncategorized
    Tags: #Global Trends

    J&J eyes rare disease expansion for future blockbuster Imaavy following successful Phase 2/3 anemia trial

    12/06/2026 Published by Pharma Biz

    Johnson & Johnson (J&J) has unveiled positive data from its pivotal Phase 2/3 clinical trial, designated as the Energy study,... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Novo Nordisk reports internal IT data breach, advising clinical trial patients to ‘remain vigilant’

    12/06/2026 Published by Pharma Biz

    Danish pharmaceutical giant Novo Nordisk has officially issued a security incident notice confirming a targeted cyberattack that compromised specific components... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Posts pagination

    Previous page Page 1 … Page 4 Page 5 Page 6 … Page 72 Next page

    Facebook

    Map

    Workday: Monday to Friday
    Working hours: 8am to 5pm
    Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

    Please enable JavaScript in your browser to complete this form.
    Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates
    Loading

    Online Members

    Recent Comments

    • GauTruc on New Biotech Startup Secures $125 Million to Advance Pain Medication
    HEALTHCARE INSIGHTS
    All rights reserved